Metastatic Non-Small Cell Lung Cancer with Alexander Drilon, MD: Case 2
Metastatic Non-Small Cell Lung Cancer with Alexander Drilon, MD
Case Scenario 2:
SR is a 58 year-old female, former smoker 20 PPY (stopped smoking 5 years ago), presents with cough and SOB. She experienced an unintended 10 lb weight loss over a 3-month period.
- Tissue analysis identified adenocarcinoma, EGFR, ALK, ROS1 negative.
- PD-L1 expression was < 50%.
- Patient has stage IV disease with metastasis to the liver.
- A chest CT scan confirmed the primary mass in the upper lobe of the right lung, with several pleural metastases and malignant pleural effusion.
- MRI of the brain was negative for intracranial metastases.
- Patient has not complained of blood in the sputum.
- Patient has history of well controlled HTN.
- Her performance status was 1 at diagnosis.
Patient was started on carboplatin/paclitaxel/bevacizumab for 4 cycles. Patient showed partial response and was continued on bevacizumab until progression.
Recent Videos
Related Content
Amivantamab/Lazertinib Shows OS and PFS Benefits in EGFR-Mutated NSCLC
April 21st 2025Article
During a live event, Xiuning Le, MD, PhD, discussed updated intracranial efficacy, overall survival, and safety of amivantamab plus lazertinib in patients with EGFR-mutated non–small cell lung cancer.
Read More
